Skip to content

Rhythm Pharmaceuticals, Inc. RYTM Strategic investments

Strategic investments at other companies

Chubb logo
ChubbCB
$11.17B+21.1%
Norfolk Southern logo
Norfolk SouthernNSC
$4.12B+2.8%
Monster Beverage logo
Monster BeverageMNST
$770.4M
Tenet Healthcare logo
Tenet HealthcareTHC
$3.81B+24.1%
Elevance Health logo
Elevance HealthELV
$11.01B+8.3%
Dominion Energy logo
Dominion EnergyD
$378M+5.0%

Other financials

Income statement

See full
Revenue$60.1M+83.8%
Gross profit$53.0M+82.3%
Operating income-$52.4M-11.4%
Net income-$55.6M-12.4%
EPS (diluted)-$0.83-2.5%

Balance sheet

See full
Cash & equivalents$62.1M-41.4%
Total debt$112.3M-1.1%
Total equity$122.9M+549%
Total assets$442.3M+14.4%

Cash flow

See full
Operating cash flow-$44.2M-9.5%
CapEx$238.3K
Free cash flow-$29.2M-2.4%

Valuation

See full
Market cap$6.64B+77.3%
Enterprise value$6.69B+78.4%
P/S30.6×+3.2×

Profitability

See full
Gross margin89.4%-0.2pp
Operating margin-90.9%-19.8pp
Net margin-93.3%-18.2pp
FCF margin-61.5%-14.1pp

Returns & leverage

See full
Return on equity-285.8%-68.9pp
Debt / equity0.9×-5.1×
Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLongTermInvestments.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s strategic investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s strategic investments?
Rhythm Pharmaceuticals, Inc. (RYTM) reported strategic investments of $2.52M in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s strategic investments changed year-over-year?
Rhythm Pharmaceuticals, Inc.'s strategic investments decreased by 64.8% year-over-year, from $7.14M to $2.52M.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s strategic investments?
Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s strategic investments has grown at a -27.4% compound annual growth rate (CAGR), from $11.82M to $3.29M.